DAVIS MARSHALL: Open Payments
NPI 1962874883 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,635 in 91 payments from 17 companies in 2025. Trend: 2023 $1,668 · 2024 $1,961 · 2025 $1,635
Food & beverage: $1,635
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $424 |
| Janssen Biotech, Inc. | 11 | $237 |
| Gilead Sciences, Inc. | 7 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $93 |
| Phathom Pharmaceuticals, Inc. | 6 | $73 |
| Lilly USA, LLC | 3 | $66 |
| QOL Medical, LLC | 2 | $63 |
| Madrigal Pharmaceuticals | 3 | $62 |
| GENZYME CORPORATION | 2 | $48 |
Products named: TREMFYA, RINVOQ, CREON, ENTYVIO, XIFAXAN, DUPIXENT, VOQUEZNA, OMVOH.
Industry payments across NC — which companies pay providers there.
